Steven D Ertel Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Steven D Ertel.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Steven D Ertel. Steven D Ertel is a EVP & Chief Operating Officer in ACCELERON PHARMA INC ($XLRN) and a SVP & Chief Business Officer in ACCELERON PHARMA INC ($XLRN).

Address: 128 SIDNEY STREET CAMBRIDGE 02139 MA

Companies in which Steven D Ertel is an Insider

ACCELERON PHARMA INC

Trading Symbol: XLRN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Steven D Ertel: EVP & Chief Operating Officer, SVP & Chief Business Officer
Holdings: 136,977 shares
Current Value: $3,251,834
Latest Transaction: Mar 14 2017
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Steven D Ertel

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 14 2017XLRNACCELERON PHARMA I ...Ertel Steven DEVP & Chief Operati ...Option ExerciseA30.1747,3001,427,04147,300
Mar 14 2017XLRNACCELERON PHARMA I ...Ertel Steven DEVP & Chief Operati ...GrantA0.007,9000136,977144.9 K to 137 K (-5.45 %)
Jan 06 2017XLRNACCELERON PHARMA I ...Ertel Steven DEVP & Chief Operati ...SellS27.611,90052,459129,077131 K to 129.1 K (-1.45 %)
Jan 06 2017XLRNACCELERON PHARMA I ...Ertel Steven DEVP & Chief Operati ...SellS26.9260016,152130,977131.6 K to 131 K (-0.46 %)
Jul 07 2016XLRNACCELERON PHARMA I ...Ertel Steven DEVP & Chief Operati ...Option ExerciseM5.284,42123,3431,883
Jul 07 2016XLRNACCELERON PHARMA I ...Ertel Steven DEVP & Chief Operati ...BuyM5.284,42123,343131,577127.2 K to 131.6 K (+3.48 %)
Jul 06 2016XLRNACCELERON PHARMA I ...Ertel Steven DEVP & Chief Operati ...Option ExerciseM5.283,96620,9406,304

View all Steven D Ertel insider transactions.